Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trialYoshimasa Shiraishi, Isamu Okamoto, Shogo Nomura et al.|The Lancet Respiratory Medicine|2024Cited by 43
Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the <scp><i>BRAF</i> V600E</scp> mutationYosuke Dotsu, Hiroshi Mukae, Minoru Fukuda et al.|Thoracic Cancer|2020Cited by 5
Heterogeneity of EGFR mutations in a patient treated with gefitinib as neo-adjuvant chemotherapyKosuke Mizoguchi, Shigeru Kohno, Junya Fukuoka et al.|Cancer Treatment Communications|2015Cited by 0
Severe esophagitis directly induced by accumulation of crizotinib-residue at the esophageal mucosa proven with polarizing microscope examinationYasuhiro Umeyama, Hiroshi Mukae, Hirokazu Taniguchi et al.|Institutional Repositories DataBase (IRDB)|2023Cited by 0